NCT04219475View on ClinicalTrials.gov

Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients

SuspendedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Glioblastoma
Trial Locations (4)

Unknown

Rambam medical center, Haifa

Rabin medical center, Petah Tikva

Sourasky medical center, Tel Aviv

Sheba medical center, Tel Litwinsky

Sponsors

Lead Sponsor

OncoHost Ltd.
All Listed Sponsors
lead

OncoHost Ltd.

INDUSTRY

NCT04219475 - Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients | Biotech Hunter | Biotech Hunter